Lexicon Pharmaceuticals is a biopharmaceutical company focused on discovering and developing drugs to treat human diseases. Its pipeline includes candidates for irritable bowel syndrome, type 2 diabetes, rheumatoid arthritis, carcinoid syndrome, and glaucoma. The company has collaborations with major pharmaceutical companies and other organizations.
Senior Vice President and Chief Commercial Officer
1 past transactions
Coelacanth
Acquisition in 2001
Coelacanth, which uses proprietary chemistry technologies to rapidly discover new chemical entities for drug development.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.